Lymphact Information

We are a biopharmaceutical start-up focused on developing state-of-the-art personalised treatments targeting cancer and chronic viral diseases. Our first product can target not only cancer and virus-infected cells, but also chemotherapy-resistant cancer stem cells and viral reservoirs, believed to cause disease recurrence. An improved anti-tumor function and the absence of severe associated side-effects are distinctive and unique features of our therapeutic approach.